| ¿ Cuál es la efectividad de un producto compuesto por calcipotriol y dipropionato de betametasona en distintas poblaciones de pacientes afectados de psoriasis? P Van de Kerkhof Medicina Cutánea Ibero-Latino-Americana 33 (1), 43, 2005 | | 2005 |
| ‘Biologicals’ in de praktijk: prospectieve cohortmonitoring van ‘high need’psoriasispatiënten RJB Driessen, MAM Berends, PCM van de Kerkhof, E de Jong Dermatologie Venereologie, 162, 2007 | | 2007 |
| ‘Happy’drug survival of adalimumab, etanercept and ustekinumab in psoriasis in daily practice care: results from the BioCAPTURE network J Van den Reek, J Zweegers, W Kievit, ME Otero, PPM Van Lümig, ... British Journal of Dermatology 171 (5), 1189-1196, 2014 | 116 | 2014 |
| 'Jeuk is erger dan pijn': Diagnostiek en behandeling van jeuk bij chronische huidaandoeningen. AWM Evers, P Duller, EWM Verhoeven, AIM van Laarhoven, ... Gedragstherapie, 2008 | | 2008 |
| 'Restless legs': flebologie? Een casuïstiek CJM van der Vleuten, MJM de Rooij, PCM van de Kerkhof | | 2000 |
| “Patient-centered treatment” for mild-to-moderate psoriasis MIA Koetsier, PCM van de Kerkhof Journal of Dermatological Treatment 26 (1), 1-6, 2015 | 4 | 2015 |
| [Others]-JUVENILE PSORIASIS IS ASSOCIATED WITH ERAP1 AND IL23R LOCI, LCE3C_LCE3B DELETION AND HLA-C* 06. A OOSTVEEN, J BERGBOER, M DE JAGER, M DEN HEIJER, I JOOSTEN, ... European Journal of Pediatric Dermatology 22 (1), 2012 | | 2012 |
| [Others]-THE INFLUENCE OF TREATMENTS ON THE CHILDREN’S DERMATOLOGY LIFE QUALITY INDEX (CDLQI) IN JUVENILE PSORIASIS: A LONGITUDINAL STUDY IN DAILY PRACTICE FROM THE CHILD-CAPTURE. A OOSTVEEN, M DE JAGER, P VAN DE KERKHOF, R DONDERS, ... European Journal of Pediatric Dermatology 22 (1), 2012 | | 2012 |
| 0.3% Tacrolimus gel and 0.5% Tacrolimus cream show efficacy in mild to moderate plaque psoriasis: Results of a randomized, open-label, observer-blinded study. JP Ortonne, PCM van de KERKHOF, JC Prinz, T Bieber, M Lahfa, ... | 48 | 2006 |
| 104 Understanding sensitive skin: a role of inflammation, mast cells, and skin barrier NE Uzunbajakava, R Richters, D Falcone, P Caspers, G Puppels, ... Journal of Investigative Dermatology 136 (9), S178, 2016 | | 2016 |
| 112 Assessment of skin perturbation by means of non-invasive in vivo measurement of inflammatiory biomarkers and confocal reflectance microscopy D Falcone, NE Uzunbajakava, M Peppelman, K Salk, P Spee, ... Journal of Investigative Dermatology 136 (9), S179, 2016 | | 2016 |
| 1261 European evidence-based (S3) guideline for the treatment of acne–update 2016–short version A Nast, B Dréno, V Bettoli, ZB Mokos, K Degitz, C Dressler, AY Finlay, ... | | |
| 13632 Long-term safety of tildrakizumab in patients 65 years of age or older with moderate to severe psoriasis: Pooled analysis through 3 years (148 weeks) from reSURFACE 1 and … PC van de Kerkhof, E Daudén, I Pau-Charles, AS López, R Langley Journal of the American Academy of Dermatology 83 (6), AB120, 2020 | 2 | 2020 |
| 2 A sequential double immunoenzymic staining procedure to obtain cell kinetic information in normal and hyper-proliferative epidermis E PEJ, S de Mare, JJ Rijzewijk, PCM van de Kerkhof, FW Bauer PDF hosted at the Radboud Repository of the Radboud University Nijmegen 21, 25, 1989 | | 1989 |
| 2.1 EPIDERMAL PROLIFERATION AND DIFFERENTIATION, COM-POSITION OF THE INFLAMMATORY INFILTRATE AND THE EXTRACELLULAR MATRIX IN THE MARGIN OF THE SPREADING PSORIATIC LESION. E de Jong, J Schalkwijk, PCM van de Kerkhof DYNAMICS QF EPIDERMAL GROWTH AND INFLAMMATION IN PSORIASIS, 37, 0 | | |
| 2.2 THE INTERRELATION BETWEEN INFLAMMATION AND EPIDER-MAL PROLIFERATION IN NORMAL SKIN FOLLOWING EPICUTA-NEOUS APPLICATION OF LEUKOTRIENE B4; AN IMMUNOHIS-TOCHEMICAL STUDY. E de Jong, PEJ van Erp, I van Vlijmen, PCM van de Kerkhof DYNAMICS QF EPIDERMAL GROWTH AND INFLAMMATION IN PSORIASIS, 50, 0 | | |
| 3.2 TOPICAL APPLICATION OF 13-CIS-RETINOIC ACID IN THE TREATMENT OF CHRONIC PLAQUE PSORIASIS. E de Jong, HFC Rulo, E Sendagorta, BM Czametzki, PCM van de Kerkhof DYNAMICS QF EPIDERMAL GROWTH AND INFLAMMATION IN PSORIASIS, 90, 0 | | |
| 3.3 SHORT-CONTACT DITHRANOL TREATMENT OF PSORIASIS, USING A NOVEL EMULSIFYING OINTMENT (HERMAL-AW"): CHANGES IN CLINICAL SCORES AND IN PARAMETERS FOR INFLAMMATION … E de Jong, PCM van de Kerkhof DYNAMICS QF EPIDERMAL GROWTH AND INFLAMMATION IN PSORIASIS, 99, 0 | | |
| 3.6 EFFECT OF TOPICAL TREATMENT WITH BUDESONIDE (PREFE RID") ON CLINICAL SCORES, AND ON PARAMETERS FOR PROLI FERATION, KERATINIZATION AND INFLAMMATION IN PSORIA SIS. E de Jong, A de Zwart, PJJ Wauben-Penris, С Korstanje, ... DYNAMICS QF EPIDERMAL GROWTH AND INFLAMMATION IN PSORIASIS, 136, 0 | | |
| 4.1 INFLAMMATORY LINEAR VERRUCOUS EPIDERMAL NEVUS (ILVEN) VERSUS LINEAR PSORIASIS; A CLINICAL, HIS-TOLOGICAL AND IMMUNOHISTOCHEMICAL STUDY. E de Jong, HFC Rulo, PCM van de Kerkhof DYNAMICS QF EPIDERMAL GROWTH AND INFLAMMATION IN PSORIASIS, 155, 0 | | |
